Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04823988 · ClinicalTrials.gov registry record
Emotional, Social, Cognitive and Behavioral Sequalae of the COVID-19 Pandemic
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 2,086
- Enrollment target
NCT04823988: Completed study, sponsored by National Institute of Mental Health (NIMH).
NCT04823988 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 2,086 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04823988 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 2,086 participants
- Enrollment target
Study Summary
Background: COVID-19 has caused a high rate of deaths. The steps taken to control its spread have caused social isolation, changes in lifestyle, economic turmoil, and increased work-related stress. As a result, there has been a rise in mental and physical health problems. These burdens are particularly severe for people with a history of mental illness. Researchers want to learn more about the relationship between stressors related to COVID-19 and self-rated measures of anxiety and other variables. Objective: To better understand the impact of this stressful time on people s lives and families. Also, to learn the strategies people have been using to deal with the COVID-19 pandemic. Eligibility: Adults ages 18 and older. Design: This is an online study. Participants will fill out surveys online. The surveys will ask about their mood, anxiety, medical history, substance use, and COVID-19 stressors. Participants will complete an online task. For the task, they will stare at the center of a computer screen. When they see certain images, they will indicate the location of that image as quickly as possible. It will take about 1.5 hours for participants to complete the surveys and tasks. They may be contacted again if additional data is needed. Some participants may have taken part in other NIH studies. If so, their new data may be linked to their previously collected data.
Primary Outcome
The primary objective is to examine the impact of COVID-19 pandemic and the precarious availability of the vaccine on mental health and cognitive function, in function of a host of factors, including parental situation, history of mental illness, demographic factors, clinical history, and other demographic variables.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,086 participants |
| Start Date | 2021-04-13 |
| Est. Completion | 2023-04-26 |
What the finished NCT04823988 record still lists
NCT04823988 is an observational study that tracks outcomes without assigning an intervention. Its 2,086 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04823988 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04823988 about?
NCT04823988 is a clinical study titled "Emotional, Social, Cognitive and Behavioral Sequalae of the COVID-19 Pandemic". Background: COVID-19 has caused a high rate of deaths. The steps taken to control its spread have caused social isolation, changes in lifestyle, economic turmoil, and increased work-related stress. As a result, there has been a rise in mental and physical health problems. These burdens are particul...
What is the current status of trial NCT04823988?
This trial is currently completed. The enrollment target is 2,086 participants. The study started on 2021-04-13. Estimated completion is 2023-04-26.
Who is sponsoring clinical trial NCT04823988?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04373564 · 2,076 participants · Phase 4
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- NCT04649242 · 2,100 participants · Phase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- NCT05206331 · 2,100 participants · Phase 4
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study
- NCT05270499 · 2,100 participants
Aveir VR Real-World Evidence Post-Approval Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI